tiprankstipranks
Trending News
More News >
Xvivo Perfusion AB (XVIPF)
OTHER OTC:XVIPF
US Market

Xvivo Perfusion AB (XVIPF) Technical Analysis

Compare
11 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
4Neutral
8Bearish
Technical Analysis Consensus
Buy
3Bullish
4Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Xvivo Perfusion AB’s (XVIPF) Moving Averages Convergence Divergence (MACD) indicator is -0.33, suggesting Xvivo Perfusion AB is a Sell.
Xvivo Perfusion AB’s (XVIPF) 20-Day exponential moving average is 30.54, while Xvivo Perfusion AB’s (XVIPF) share price is $30.95, making it a Buy.
Xvivo Perfusion AB’s (XVIPF) 50-Day exponential moving average is 31.47, while Xvivo Perfusion AB’s (XVIPF) share price is $30.95, making it a Sell.

Xvivo Perfusion AB (XVIPF) Pivot Points

Jul 12, 2025, 05:51 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
29.65
29.90
30.20
30.45
30.75
31.00
31.30
Fibonacci
29.90
30.11
30.24
30.45
30.66
30.79
31.00
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Xvivo Perfusion AB (XVIPF) Moving Averages

Jul 12, 2025, 05:51 AM
Period
Simple
Exponential
MA5
30.53Buy
30.51Buy
MA10
30.23Buy
30.36Buy
MA20
30.27Buy
30.54Buy
MA50
31.66Sell
31.47Sell
MA100
33.50Sell
33.66Sell
MA200
38.66Sell
38.49Sell
Xvivo Perfusion AB’s (XVIPF) 10-Day exponential moving average is 30.36, while Xvivo Perfusion AB’s (XVIPF) share price is $30.95, making it a Buy.
Xvivo Perfusion AB’s (XVIPF) 100-Day exponential moving average is 33.66, while Xvivo Perfusion AB’s (XVIPF) share price is $30.95, making it a Sell.
Xvivo Perfusion AB’s (XVIPF) stock price is $30.95 and Xvivo Perfusion AB’s (XVIPF) 50-day simple moving average is 31.66, creating a Sell signal.
Xvivo Perfusion AB’s (XVIPF) stock price is $30.95 and Xvivo Perfusion AB’s (XVIPF) 100-day simple moving average is 33.50, creating a Sell signal.
Xvivo Perfusion AB’s (XVIPF) stock price is $30.95 and Xvivo Perfusion AB’s (XVIPF) 200-day simple moving average is 38.66, creating a Sell signal.

Xvivo Perfusion AB (XVIPF) Technical Indicators

Jul 12, 2025, 05:51 AM
Name
Value
Implied Action
RSI (14)
51.58
Neutral
STOCH (9,6)
68.54
Neutral
STOCHRSI (14)
83.64
Sell
MACD (12,26)
-0.33
Sell
ADX (14)
14.26
Buy
Williams %R
0.00
Sell
CCI (14)
54.81
Neutral
ATR (14)
0.90
-
Ultimate Oscillator
56.58
Neutral
ROC
6.72
Buy
Xvivo Perfusion AB’s (XVIPF) Relative Strength Index (RSI) is 51.58, creating a Neutral signal.
Xvivo Perfusion AB’s (XVIPF) Trend Strength Indicator (ADX) is 14.26, creating a Buy signal.
Xvivo Perfusion AB’s (XVIPF) Commodity Channel Index (CCI) is 54.81, creating a Neutral signal.
Xvivo Perfusion AB’s (XVIPF) Price Rate of Change (ROC) is 6.72, creating a Buy signal.

FAQ

Is XVIPF a Buy, Hold, or Sell?
Based on XVIPF’s technical indicators, XVIPF is a Hold.
    What is XVIPF’s RSI (14)?
    XVIPF’s RSI (14) is 51.58, which suggests XVIPF is a Neutral.
      What is XVIPF’s MACD?
      XVIPF’s MACD is -0.33, which suggests XVIPF is a Sell.
        What is XVIPF’s 5-day moving average?
        XVIPF’s 5-day moving average is 30.53, which suggests XVIPF is a Buy.
          What is XVIPF’s 20-day moving average?
          XVIPF 20-day moving average is 30.27, which suggests XVIPF is a Buy.
            What is XVIPF’s 50-day moving average?
            XVIPF’s 50-day moving average is 31.66, which suggests XVIPF is a Sell.
              What is XVIPF’s 200-day moving average?
              XVIPF’s 200-day moving average is 38.66, which suggests XVIPF is a Sell.
                What is XVIPF’s Williams % R (14)?
                XVIPF’s Williams % R (14) is 0.00, which suggests XVIPF is a Sell.
                  What is XVIPF’s CCI (14)?
                  XVIPF’s CCI (14) is 54.81, which suggests XVIPF is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis